UC Cooperative Extension spent 2024 investigating the extent of a new beetle threat in the almond-growing regions of the state and learning from peers in Australia, where the insect has been a persistent scourge for a decade.

Born on the side of Highway 99, a preterm baby gets the best chance at life, thanks to Sacramento Fire Department Engine 6 and UC Davis NICU teams.

FDA approves algorithm developed by UCSF researcher that provides calibrated electrical pulses to fend off stiffness and involuntary movements before they arise.

The study uses CRISPR to correct sickle cell mutation and aims to free patients of the disease.

Algae are the new delivery drivers: they are tiny enough to float in inhalable liquid particles and travel deep inside the lungs of mice where they drop off drugs to fight pneumonia.

A UC Davis study found that deleting a cluster of genes in wheat may reduce wheat allergies without harming breadmaking.

Ronan, the only non-human mammal to demonstrate highly precise beat keeping, continues to challenge our understanding of biomusicality.

NOAA support helps protect monitoring programs, weather forecasting, and technology development essential for public safety.

A first-of-its-kind study tested the safety of psilocybin and found that patients experienced clinically significant improvements in mood, cognition, and motor function that lasted for weeks after the drug was out of their systems.

A person happily gnawing away on a large piece of gum could unleash more than 3,000 microplastic particles, according to the UCLA team.

The University of California today (April 24) announced the 2025 cohort of UC President’s Lindau Nobel Laureate Meetings Fellows, 42 outstanding young scientists and economists from across the UC system who will join Nobel laureates from around the world at two renowned scholarly gatherings in Lindau, Germany.

A new, neuroplasticity-promoting drug closely related to LSD harnesses the psychedelic’s therapeutic power with reduced hallucinogenic potential, according to UC Davis research.